Hair regrowth hope for severe baldness condition in Final-Stage trial
NCT ID NCT02557074
Summary
This study tested whether low-dose injections of a medication called IL-2 could help regrow hair in adults with severe alopecia areata, a condition causing patchy or total hair loss. It was a Phase 3 trial comparing the injections to a placebo (dummy treatment) in 44 participants over 12 months. The goal was to see if the treatment could lead to significant, lasting hair regrowth for people whose condition had not improved with other standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP-HM - La timone - Dermatologie
Marseille, Bouche Du Rhône, 13005, France
-
AP-HP St Louis - Dermatologie
Paris, Île-de-France Region, 75000, France
-
CHI St Raphael Fréjus - Dermatologie
Fréjus, PACA, 83000, France
-
CHU Montpellier - Dermatologie
Montpellier, 34000, France
-
CHU de Nice - dermatologie
Nice, 06200, France
-
CHU de Nimes - Dermatologie
Nîmes, Languedoc-Roussillon, 30000, France
Conditions
Explore the condition pages connected to this study.